Meridian Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Meridian Wealth Partners's LLY Position: Q2 2026 in Review
Meridian Wealth Partners increased its Eli Lilly (LLY) stake by 5.4% in Q2 2026, buying an estimated $31.7K and bringing the position to 607 shares worth $728K. The position accounts for 0.09% of the portfolio, ranked #55.
Meridian Wealth Partners first reported a position in LLY in Q4 2019 and has held it in 19 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Meridian Wealth Partners held 607 shares of Eli Lilly worth $728K as of Q2 2026.
- Meridian Wealth Partners bought 31 Eli Lilly shares in Q2 2026, an estimated $31.7K.
- Eli Lilly made up 0.09% of Meridian Wealth Partners's portfolio in Q2 2026, its #55 holding.
- Meridian Wealth Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 19 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Meridian Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.